scispace - formally typeset
A

Achim Wambach

Researcher at Zentrum für Europäische Wirtschaftsforschung

Publications -  119
Citations -  1792

Achim Wambach is an academic researcher from Zentrum für Europäische Wirtschaftsforschung. The author has contributed to research in topics: Common value auction & Adverse selection. The author has an hindex of 23, co-authored 115 publications receiving 1672 citations. Previous affiliations of Achim Wambach include Center for Economic and Policy Research & University of Erlangen-Nuremberg.

Papers
More filters
Journal ArticleDOI

Incentive effects in the demand for health care: a bivariate panel count data estimation

TL;DR: In this paper, the first application of a bivariate random effects estimator in a count data setting, to permit the efficient estimation of this type of model with panel data was presented.
Journal ArticleDOI

Optimal incentive contracts under inequity aversion

TL;DR: In this paper, the authors analyze the classic moral hazard problem with the additional assumption that agents are inequity averse, and they show that the presence of inequity aversion alters the structure of optimal contracts.
Journal ArticleDOI

Regulation of Insurance Markets

TL;DR: In this paper, the authors examine the arguments for solvency regulation when consumers are fully informed of the insurer's insolvency risk, and conclude that the role of regulation in insurance markets should be confined to providing consumers with information about the default risk of insurers.
Journal ArticleDOI

Introducing Heterogeneity in the Rothschild-Stiglitz Model

TL;DR: In this article, the authors extended the model by introducing unobservable wealth in addition to the differing risks and showed that if the differences in wealth are small, different wealth types are pooled while different risks are separated.
Journal ArticleDOI

Adverse selection and categorical discrimination in the health insurance markets: the effects of genetic tests

TL;DR: The effects of new methods for risk classification, e.g., genetic tests, on health insurance markets are studied using an insurance model with state contingent utility functions on the case of treatment costs higher than the patient's willingness to pay where standard models of asymmetric information are not applicable.